Rein Therapeutics raises ~$5.05M via warrant exercises, exchanges, and private placement

Rein Therapeutics, Inc.

Holders exercise 2023 and 2024 warrants for 902,929 shares at reduced price of $1.60 per share.
Holders of 2023 warrants exchange 1,939,000 shares for pre-funded warrants plus cash payment of ~$1.599/share.
Bios affiliate purchases pre-funded warrants for 312,695 shares at $1.599 per share in private placement.
Total gross proceeds expected to be approximately $5.05 million.
Pre-funded warrants are immediately exercisable at $0.001 per share, subject to beneficial ownership limit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.